nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—Tamsulosin—DRD3—Gilles de la Tourette syndrome	0.127	0.591	CrCbGaD
Silodosin—Tamsulosin—DRD2—Gilles de la Tourette syndrome	0.0876	0.409	CrCbGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0323	0.0411	CbGpPWpGaD
Silodosin—ADRA1D—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0275	0.035	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0268	0.0341	CbGpPWpGaD
Silodosin—ADRA1D—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0267	0.034	CbGpPWpGaD
Silodosin—ADRA1D—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0249	0.0317	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0238	0.0303	CbGpPWpGaD
Silodosin—ADRA1D—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0232	0.0295	CbGpPWpGaD
Silodosin—ADRA1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0229	0.0291	CbGpPWpGaD
Silodosin—ADRA1D—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0225	0.0286	CbGpPWpGaD
Silodosin—ADRA1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0222	0.0282	CbGpPWpGaD
Silodosin—ADRA1D—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0209	0.0266	CbGpPWpGaD
Silodosin—ADRA1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0207	0.0263	CbGpPWpGaD
Silodosin—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0203	0.0258	CbGpPWpGaD
Silodosin—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0197	0.0251	CbGpPWpGaD
Silodosin—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0192	0.0245	CbGpPWpGaD
Silodosin—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0187	0.0237	CbGpPWpGaD
Silodosin—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0184	0.0234	CbGpPWpGaD
Silodosin—ADRA1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0174	0.0222	CbGpPWpGaD
Silodosin—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0174	0.0221	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0171	0.0217	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0166	0.0211	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0154	0.0196	CbGpPWpGaD
Silodosin—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0147	0.0187	CbGpPWpGaD
Silodosin—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0145	0.0184	CbGpPWpGaD
Silodosin—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0129	0.0164	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—HDC—Gilles de la Tourette syndrome	0.0122	0.0156	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0122	0.0156	CbGpPWpGaD
Silodosin—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0122	0.0155	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0119	0.0151	CbGpPWpGaD
Silodosin—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0108	0.0138	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.0098	0.0125	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00775	0.00986	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00531	0.00676	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00516	0.00657	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00481	0.00612	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00455	0.0058	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00442	0.00563	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00441	0.00561	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00436	0.00554	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00428	0.00545	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—HDC—Gilles de la Tourette syndrome	0.00422	0.00538	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00412	0.00524	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00399	0.00508	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00392	0.00499	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0039	0.00496	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0038	0.00484	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00378	0.00481	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00367	0.00467	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00361	0.0046	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00354	0.00451	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00347	0.00441	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00342	0.00435	CbGpPWpGaD
Silodosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00337	0.00428	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00337	0.00428	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00336	0.00427	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00326	0.00415	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00323	0.00411	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00321	0.00409	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00314	0.00399	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00304	0.00386	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00288	0.00367	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00288	0.00366	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00287	0.00365	CbGpPWpGaD
Silodosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00279	0.00356	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00279	0.00356	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0026	0.00331	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00256	0.00325	CbGpPWpGaD
Silodosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00248	0.00316	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00248	0.00316	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00239	0.00305	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00231	0.00294	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0022	0.0028	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00213	0.00271	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00196	0.00249	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0019	0.00242	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00182	0.00232	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00178	0.00226	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00177	0.00226	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00173	0.0022	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00163	0.00207	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00162	0.00206	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00161	0.00205	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00158	0.00201	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00157	0.002	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00148	0.00188	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00147	0.00187	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00144	0.00184	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00143	0.00182	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0014	0.00178	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00134	0.0017	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00131	0.00167	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00131	0.00166	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00127	0.00162	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00124	0.00158	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00119	0.00151	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00117	0.00149	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00113	0.00143	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00105	0.00134	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00103	0.00131	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00102	0.0013	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.00097	0.00123	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000951	0.00121	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000936	0.00119	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000915	0.00116	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000872	0.00111	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000847	0.00108	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000831	0.00106	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000789	0.001	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000775	0.000986	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000752	0.000957	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000701	0.000892	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000666	0.000847	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000553	0.000703	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000491	0.000625	CbGpPWpGaD
